Information Provided By:
Fly News Breaks for August 1, 2019
TDOC
Aug 1, 2019 | 09:12 EDT
Craig-Hallum analyst Matt Hewitt raised his price target for Teladoc to $80 from $70 saying that while catalysts continue to be back half weighted, Q2 brought a number of encouraging signs from a customer adoption/metrics standpoint as the company's multi-product approach to telemedicine continues to resonate with customers. The analyst reiterates a Buy rating on the shares.